Women want a low-dose birth control option
Talk to your appropriate patients about Kyleena: a small, low-hormone, 5-year intrauterine device (IUD)1
IN AN ONLINE SURVEY OF 1000 WOMEN CONSIDERING HORMONAL BIRTH CONTROL2:
The survey conducted by Bayer in September 2019 included women aged 18-44 who were currently taking or considering taking hormonal prescription birth control in the next 12 months.
Kyleena acts locally and provides low hormone levels
Comparison of simulated typical serum LNG concentrations3*
Kyleena provides low daily release rates1
intrauterine system) 19.5 mg
|Initial Release Rate||17.5 mcg/day after 24 days1|
|After Year 1||9.8 mcg/day1|
|Avg in Vivo Release Rate||9.0 mcg/day over 5 years1|
High contraceptive efficacy maintained over 5 years1
Kyleena is a low-dose 5-year IUD1
The efficacy of Kyleena over 5 years was studied in 1452 parous and nulliparous women aged 18-35.
Year 1: Pearl Index of 0.16; 95% upper confidence limit (CL) of 0.58; cumulative 5-year pregnancy rate, based on 13 pregnancies, estimated by the Kaplan-Meier method was 1.45%; 95% upper CL of 2.53%.
Request a Rep
Stay up to date with clinical information and virtual trainings for Kyleena.
See how Kyleena impacts bleeding
Know what patients may expect in the first 3 to 6 months and up to 5 years of use.
A non-daily contraception option
Learn more about Kyleena as a non-daily contraception option.